Fenwick & West

Curious how the proxy voting winds are shifting in Silicon Valley and top tech companies nationwide? We trawled through the last five years of voting data for companies on the S&P 100 and the Fenwick – Bloomberg Law Silicon Valley 150 List to uncover a wealth of new insights that C-suiters and board members will want to know about. Explore our insights: https://lnkd.in/eP9K546K #ESG #CorporateGovernance #SiliconValley

What does it take to lead a $4.9 billion biotech acquisition? 🧬💡 Join Fenwick partners Effie Toshav and Douglas Cogen for a fireside chat with Mitchell Gold M.D., CEO of Alpine Immune Sciences, Inc., as they dive into Alpine’s record-setting acquisition by Vertex Pharmaceuticals. Hear how Mitch navigated Alpine’s journey, what it takes to successfully lead a biotech in the current environment, the M&A process, and emerging trends in the life sciences industry. This event kicks off Fenwick's Pathways to Success Series—a must-attend for biotech leaders. Secure your spot today: https://lnkd.in/du5dsX_i #MergersAndAcquisitions #FenwickforLifeSciences #Innovation

How do you know you have made it as a tech lawyer? Not a feature in American Lawyer or The Information, or Chambers, Law 360 or other legal rankings. Getting your own card from Wiz 👨🚀 ‏‏‎ ‎and Spacecadet! Truly honored to have merited inclusion in this year's edition. I wake up everyday excited to work with amazing entrepreneurs and investors and helping to pave the way for innovation to thrive. Here's to an exciting 2025, guiding companies through the labyrinth of legal challenges...

Just one month left until the Treasury Department begins cracking down on U.S.-based investments in sensitive Chinese tech like semiconductors and microelectronics, quantum information technologies, and artificial intelligence—are you ready? Learn which transactions are covered and how you can prepare for a January 2 effective date in the latest client alert from Mark Ostrau, Melissa L. Duffy, Robert Slack, Sofia (Panero) Chalat, Trevor Coval, and Gregory Rohling: https://lnkd.in/euKPA3xd

Meet Meredith Mommers, a powerhouse in antitrust law and the newest counsel in Fenwick’s regulatory practice in Washington, DC!     Meredith brings a wealth of experience guiding global companies through the complexities of critical antitrust matters—spanning risk assessment, multi-jurisdictional filings, second request strategies, and more.     Her strategic insight will be invaluable as we continue to support cutting-edge companies navigating today’s regulatory challenges.     Welcome to the team, Meredith! Explore her background: https://lnkd.in/epEk24Xi    #Antitrust #Regulatory #Innovation 

Happy Thanksgiving! 🦃🍁   Today and every day, we’re grateful for the opportunity to work alongside our incredible colleagues and clients defining the future of technology and life sciences. Wishing you a safe and joyful holiday! #Thanksgiving #Gratitude #Innovation

🧬As we look ahead to 2025, we're revisiting the life sciences and healthcare trends that we reflected on earlier this year. At J.P. Morgan’s 2024 Healthcare Conference, three major trends emerged—each set to shape the industry’s future: 1️⃣ Cautious optimism about the industry's prospects, backed by legitimate reasons like a spurt of M&A deals, rise in licensing/partnership activities, and an uptick in new drug approvals. 2️⃣ The paradigm shift towards obesity drugs and metabolic health treatment. 3️⃣ The transformative potential of AI in healthcare and drug development, but the true “killer applications” are still on the horizon. Corporate partners Matthew Rossiter and Stefano Quintini shared their full reflections here: https://lnkd.in/en3fZvQ8 #LifeSciences #Healthcare #FenwickforLifeSciences

Who owns innovation when AI takes the reins? 🤖 Hear from Fenwick’s Antonia Sequeira and Fredrick Tsang as they dive into the game-changing Thaler v. Vidal decision and what it means for the future of life sciences and technology patents. ✔️ Only humans can be inventors on patents. But it leaves a big question open: what happens when AI and humans team up on an idea? ✔️ AI alone doesn’t qualify as an inventor—human involvement is essential. ✔️ AI is shaking up drug discovery, cutting timelines by 30%, and enabling breakthroughs in genomic analysis. Their advice? Bring legal counsel into the fold early to keep your IP strategy sharp in this evolving frontier. #AI #Innovation #FenwickforLifeSciences

Attention 1L Students! 🌟 We are thrilled to announce applications are now open for our 1L Scholarship Program and 1L Tax Hiring for Summer 2025! 💼 Interested in high-tech and life sciences? This is your chance to join a dynamic team tackling sophisticated legal challenges while gaining hands-on experience and advancing your professional development. Apply here to be part of our innovative legal practice: https://lnkd.in/eBTQA2h #1L #LegalCareer #LawStudents 

🤔 Catch up on the latest securities news before you unplug for a well-deserved holiday and relax knowing you’re prepped for the weeks ahead! Check out the latest edition of Fenwick’s Securities Law Update for important updates and reminders on: 📝 Form 10-K and proxy statement disclosures and upcoming compliance deadlines  🗳️ New proxy voting guidelines from Glass Lewis  ⏸️️ A pause to Public Company Accounting Oversight Board rulemaking  🏛️ Important SEC enforcement matters  🪙 Changes to SEC filer access and account management Read the full update here: https://lnkd.in/eqSkr4ET #Securities #PublicCompanies #CorporateLaw